HURA
TuHURA Biosciences, Inc./NV
NASDAQ · Healthcare · Biotechnology · US
$2.10
+0.48%Next report
Analyst consensus
- Next report date
- Nov 13, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.15
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -0.8%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.15 | -$0.14 | Beat 8.69% | — |
| May 15, 2026 | -$0.12 | -$0.13 | Miss -13.04% | — |
| Mar 31, 2026 | -$0.12 | -$0.13 | Miss -5.41% | — |
| Nov 14, 2025 | -$0.15 | -$0.14 | Beat 6.67% | — |
| Aug 14, 2025 | -$0.14 | -$0.21 | Miss -50.00% | — |
| May 15, 2025 | -$0.13 | -$0.15 | Miss -15.38% | — |
| Feb 26, 2025 | -$0.09 | -$8.39 | Miss -9222.22% | — |
| Nov 14, 2024 | -$0.10 | -$1.37 | Miss -1270.00% | — |
| Jun 30, 2024 | — | -$1.47 | — | — |
| Dec 30, 2023 | -$4.90 | -$8.26 | Miss -68.48% | — |
| Sep 30, 2023 | -$37 | -$0.09 | Beat 99.75% | — |
| Mar 31, 2023 | -$3.50 | -$390 | Miss -11029.78% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026